Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.24485 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.11035 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.22717 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.2295 | 53 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.23996 | 53 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.61 | 59 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.34826 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.26338 | 52 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.43631 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.24724 | 52 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.24345 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.17012 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.41861 | 56 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.09153 | 47 |